# Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

> **NCT07098351** · NA · RECRUITING · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 93 (estimated)

## Conditions studied

- Adverse Event
- Peritoneal Dialysis
- Moderate-to-severe Pruritus
- Chronic Kidney Disease-associated Itch

## Interventions

- **DRUG:** Remitch

## Key facts

- **NCT ID:** NCT07098351
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-07
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 93 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07098351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07098351, "Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07098351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*